STOCK TITAN
  1. Home
  2. News
  3. CG

The Carlyle Group Inc. - $CG STOCK NEWS

Welcome to our dedicated page for The Carlyle Group news (Ticker: $CG), a resource for investors and traders seeking the latest updates and insights on The Carlyle Group stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect The Carlyle Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of The Carlyle Group's position in the market.

News
Carlyle Credit Income Fund Schedules Second Quarter 2024 Financial Results and Investor Conference Call
Rhea-AI Summary

Carlyle Credit Income Fund (CCIF) will release its second quarter 2024 financial results on May 29, 2024, followed by an investor conference call on May 30, 2024, at 10:00 a.m. EDT. The call will be accessible via webcast on CCIF's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.7%
Tags
earnings
-
News
Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreement
Rhea-AI Summary
Teva Pharmaceutical Industries and Launch Therapeutics collaborate to advance Teva's Dual-Action Asthma Rescue Inhaler program TEV-‘248, with a strategic funding agreement of up to $150 million. The program aims to be the first ICS-SABA for both adult and pediatric asthma indications, combining fluticasone propionate and albuterol sulfate.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
none
-
News
SER Welcomes New Investment from TA to Accelerate Growth
Rhea-AI Summary
SER, a global Intelligent Content Automation software vendor, secures a strategic growth investment from TA Associates in partnership with Carlyle. The investment aims to fuel international expansion, AI innovation, and product enhancement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.18%
Tags
none
News
Carlyle Credit Income Fund Schedules First Quarter 2024 Financial Results and Investor Conference Call
Rhea-AI Summary
Carlyle Credit Income Fund (CCIF) will release its financial results for the first quarter of 2024 on February 29, 2024. The conference call to discuss the results will be held on March 1, 2024, at 10:00 a.m. EDT and will be available via public webcast on CCIF's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.9%
Tags
earnings
-
News
Carlyle Announces Acquisition of $415 Million Private Student Loan Portfolio and Strategic Investment in Monogram
Rhea-AI Summary
Carlyle (NASDAQ: CG) has announced the acquisition of a $415 million private student loan portfolio and a strategic investment into Monogram LLC, a leading provider of finance solutions for students. Monogram will partner with Carlyle to originate, acquire, and manage high-quality third-party private student loan assets. The platform offers customizable private-label programs, school sales and marketing support, active portfolio management, and loan loss protection. Monogram currently has more than $7 billion in private student loans under management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.28%
Tags
acquisition
-
News
DecisionRx Announces $100 Million Credit Facility with Carlyle
Rhea-AI Summary
DecisionRx, Inc. (Ticker: DCRX) secures $100 million credit facility with Carlyle to support its comprehensive medication therapy optimization program. The financing will fund lab testing and medication reviews for over 100,000 patients, aiming to reduce total cost of care per Medicare patient by over $3,600 per year. Carlyle also receives the option to acquire 25% of DecisionRx's equity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
none
News
NineDot Energy Raises $225 Million in Equity Financing to Build and Operate Distributed Battery Energy Storage Projects
Rhea-AI Summary
NineDot Energy (NASDAQ: NINE) secures $225 million equity capital commitment from Manulife Investment Management and Carlyle, bringing its total capital base to approximately $400 million. The funding will support the development of community-scale battery energy storage systems in the New York City area, in line with New York Governor Hochul's sustainable energy roadmap. The company aims to achieve 400 megawatts of battery storage capacity in development by the end of 2026 while adhering to stringent safety requirements set by the New York City Fire Department.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.66%
Tags
none
-
News
Carlyle and Insight Partners to Invest in Exiger, a High-Growth AI Supply Chain Risk & Resilience Software Company, in Partnership with Management
Rhea-AI Summary
Exiger (NASDAQ: CG) receives a majority investment from Carlyle and Insight Partners to continue investing in its award-winning AI solutions for supply chain management. The company's management, founders, and existing investor Carrick Capital Partners will reinvest equity as part of this transaction. Exiger's AI technology transforms the way organizations identify and manage risk, reduce cost, and increase resilience across their supplier and third-party ecosystems. The company serves over 500 customers globally, including 150 of the Fortune 500, and supports more than 50 government agencies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.77%
Tags
partnership AI
-
News
CARLYLE CREDIT INCOME FUND PRICES OFFERING OF PREFERRED SHARES
Rhea-AI Summary
Carlyle Credit Income Fund (CCIF) has announced the pricing of an offering of an additional 800,000 8.75% Series A Preferred Shares due 2028, resulting in net proceeds of approximately $19.3 million. The Preferred Shares are rated 'BBB+' by Egan-Jones Ratings Company, an independent rating agency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
offering
News
McDonald's to Acquire Carlyle's Stake in McDonald's China
Rhea-AI Summary
McDonald's Corporation (MCD) to Increase Stake in China Business, CITIC Consortium to Maintain Control: McDonald's Corporation (NYSE: MCD) and global investment firm Carlyle (NASDAQ: CG) announced that McDonald's will acquire Carlyle's minority ownership stake in the strategic partnership operating its business in mainland China, Hong Kong, and Macau. The CITIC Consortium will maintain its controlling ownership stake, with McDonald's increasing its stake from 20% to 48%. The business has seen over 30% systemwide sales growth in the market year-to-date since September 2019, and the partners will continue to work together to execute the brand's growth strategy in the market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
acquisition
Stock CG logo
The Carlyle Group Inc.

Nasdaq:CG

CG Rankings

#628 Ranked by Market Cap
#2132 Ranked by Stock Gains
#1016 Ranked by Dividends

CG Stock Data

14.93B
263.49M
32.17%
60.11%
4.29%
Portfolio Management
Finance and Insurance
Link
United States of America
WASHINGTON

About CG

carlyle is a global investment firm with $325 billion of assets under management. our purpose is to invest wisely and create value on behalf of our investors, portfolio companies and the communities in which we live and invest. founded in 1987 in washington, dc, carlyle has grown into one of the world’s largest and most successful global investment firms, with nearly 1,850 people operating in 26 offices across five continents.